{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T17:13:44Z","timestamp":1782494024571,"version":"3.54.5"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,11,9]],"date-time":"2011-11-09T00:00:00Z","timestamp":1320796800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1007\/s11739-011-0719-z","type":"journal-article","created":{"date-parts":[[2011,11,8]],"date-time":"2011-11-08T02:10:31Z","timestamp":1320718231000},"page":"103-111","source":"Crossref","is-referenced-by-count":35,"title":["Recent advances in understanding ulcerative colitis"],"prefix":"10.1007","volume":"7","author":[{"given":"Antonio","family":"Di Sabatino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Biancheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Rovedatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas Thornton","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gino Roberto","family":"Corazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,11,9]]},"reference":[{"key":"719_CR1","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1053\/j.gastro.2011.01.055","volume":"140","author":"J Cosnes","year":"2011","unstructured":"Cosnes J, Gower-Rousseau C, Seksik P et al (2011) Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 140:1785\u20131794","journal-title":"Gastroenterology"},{"key":"719_CR2","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1136\/gut.2007.122143","volume":"57","author":"CN Bernstein","year":"2008","unstructured":"Bernstein CN, Shanahan F (2008) Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel diseases. Gut 57:1185\u20131191","journal-title":"Gut"},{"key":"719_CR3","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/ng.764","volume":"43","author":"CA Anderson","year":"2011","unstructured":"Anderson CA, Boucher G, Lees CW et al (2011) Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet 43:246\u2013252","journal-title":"Nat Genet"},{"key":"719_CR4","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1038\/ng.483","volume":"41","author":"JC Barrett","year":"2009","unstructured":"UK IBD Genetics Consortium, Barrett JC, Lee JC et al (2009) Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region. Nat Genet 41:1330\u20131334","journal-title":"Nat Genet"},{"key":"719_CR5","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/ng.549","volume":"42","author":"DP McGovern","year":"2010","unstructured":"McGovern DP, Gardet A, T\u00f6rkvist L et al (2010) Genome-wide association identifies multiple ulcerative colitis susceptibility loci. Nat Genet 42:332\u2013337","journal-title":"Nat Genet"},{"key":"719_CR6","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1242\/jcs.014878","volume":"121","author":"E Sabath","year":"2008","unstructured":"Sabath E, Negoro H, Beaudry S et al (2008) Galpha12 regulates protein interactions within the MDCK cell tight junction and inhibits tight-junction assembly. J Cell Sci 121:814\u2013824","journal-title":"J Cell Sci"},{"key":"719_CR7","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1136\/gut.2009.182170","volume":"58","author":"L Rovedatti","year":"2009","unstructured":"Rovedatti L, Kudo T, Biancheri P et al (2009) Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel disease. Gut 58:1629\u20131636","journal-title":"Gut"},{"key":"719_CR8","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.3109\/00365528809090183","volume":"23","author":"EJ Boyko","year":"1988","unstructured":"Boyko EJ, Perera DR, Koepsell TD et al (1988) Effects of cigarette smoking on the clinical course of ulcerative colitis. Scand J Gastroenterol 23:1147\u20131152","journal-title":"Scand J Gastroenterol"},{"key":"719_CR9","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/00054725-200207000-00007","volume":"8","author":"IE Koutroubakis","year":"2002","unstructured":"Koutroubakis IE, Vlachonikolis IG, Kouroumalis EA (2002) Role of appendicitis and appendectomy in the pathogenesis of ulcerative colitis: a critical review. Inflamm Bowel Dis 8:277\u2013286","journal-title":"Inflamm Bowel Dis"},{"key":"719_CR10","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1136\/gut.51.6.808","volume":"51","author":"GL Radford-Smith","year":"2002","unstructured":"Radford-Smith GL, Edwards JE, Purdie DM et al (2002) Protective role of appendicectomy on onset and severity of ulcerative colitis and Crohn\u2019s disease. Gut 51:808\u2013813","journal-title":"Gut"},{"key":"719_CR11","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1007\/BF01303165","volume":"38","author":"B Katschinski","year":"1993","unstructured":"Katschinski B, Fingerle D, Scherbaum B et al (1993) Oral contraceptive use and cigarette smoking in Crohn\u2019s disease. Dig Dis Sci 38:1596\u20131600","journal-title":"Dig Dis Sci"},{"key":"719_CR12","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1365-2036.2011.04784.x","volume":"34","author":"SS Chan","year":"2011","unstructured":"Chan SS, Luben R, Bergmann MM et al (2011) Aspirin in the aetiology of Crohn\u2019s disease and ulcerative colitis: a European prospective cohort study. Aliment PharmacolTher 34:649\u2013655","journal-title":"Aliment PharmacolTher"},{"key":"719_CR13","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s10620-006-3103-5","volume":"51","author":"AM Meyer","year":"2006","unstructured":"Meyer AM, Ramzan NN, Heigh RI et al (2006) Relapse of inflammatory bowel disease associated with use of nonsteroidal anti-inflammatory drugs. Dig Dis Sci 51:168\u2013172","journal-title":"Dig Dis Sci"},{"key":"719_CR14","doi-asserted-by":"crossref","unstructured":"Di Sabatino A, Biancheri P, Rovedatti L et al (2011) New pathogenic paradigms in inflammatory bowel disease. Inflamm Bowel Dis [Epub ahead of print]","DOI":"10.1002\/ibd.21735"},{"key":"719_CR15","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3164\/jcbn.2007003","volume":"41","author":"Y Naito","year":"2007","unstructured":"Naito Y, Takagi T, Yoshikawa T (2007) Neutrophil-dependent oxidative stress in ulcerative colitis. J Clin Biochem Nutr 41:18\u201326","journal-title":"J Clin Biochem Nutr"},{"key":"719_CR16","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1136\/gut.50.4.501","volume":"50","author":"M Carlson","year":"2002","unstructured":"Carlson M, Raab Y, Seveus L et al (2002) Human neutrophil lipocalin is a unique marker of neutrophil inflammation in ulcerative colitis and proctitis. Gut 50:501\u2013506","journal-title":"Gut"},{"key":"719_CR17","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.coph.2004.06.005","volume":"4","author":"SL Pender","year":"2004","unstructured":"Pender SL, MacDonald TT (2004) Matrix metalloproteinases and the gut: new roles for old enzymes. Curr Opin Pharmacol 4:546\u2013550","journal-title":"Curr Opin Pharmacol"},{"key":"719_CR18","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/nm0602-567","volume":"8","author":"MF Neurath","year":"2002","unstructured":"Neurath MF, Finotto S, Glimcher LH (2002) The role of Th1\/Th2 polarization in mucosal immunity. Nat Med 8:567\u2013573","journal-title":"Nat Med"},{"key":"719_CR19","doi-asserted-by":"crossref","unstructured":"Di Sabatino A, Rovedatti L, Vidali F et al (2011) Recent advances in understanding Crohn\u2019s disease. Intern Emerg Med [Epub ahead of print]","DOI":"10.1007\/s11739-011-0599-2"},{"key":"719_CR20","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1172\/JCI19836","volume":"113","author":"IJ Fuss","year":"2004","unstructured":"Fuss IJ, Heller F, Boirivant M et al (2004) Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. J Clin Invest 113:1490\u20131497","journal-title":"J Clin Invest"},{"key":"719_CR21","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.gastro.2005.05.002","volume":"129","author":"F Heller","year":"2005","unstructured":"Heller F, Florian P, Bojarski C et al (2005) Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology 129:550\u2013564","journal-title":"Gastroenterology"},{"key":"719_CR22","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1111\/j.1572-0241.1999.01145.x","volume":"94","author":"B Moum","year":"1999","unstructured":"Moum B, Ekbom A, Vatn MH et al (1999) Change in the extent of colonoscopic and histological involvement in ulcerative colitis over time. Am J Gastroenterol 94:1564\u20131569","journal-title":"Am J Gastroenterol"},{"key":"719_CR23","doi-asserted-by":"crossref","first-page":"4819","DOI":"10.3748\/wjg.v12.i30.4819","volume":"12","author":"KS Rothfuss","year":"2006","unstructured":"Rothfuss KS, Stange EF, Herrlinger KR (2006) Extraintestinal manifestations and complications in inflammatory bowel diseases. World J Gastroenterol 12:4819\u20134831","journal-title":"World J Gastroenterol"},{"key":"719_CR24","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1111\/j.1572-0241.2003.07696.x","volume":"98","author":"SI Gan","year":"2003","unstructured":"Gan SI, Beck PL (2003) A new look at toxic megacolon: an update and review of incidence, etiology, pathogenesis, and management. Am J Gastroenterol 98:2363\u20132371","journal-title":"Am J Gastroenterol"},{"key":"719_CR25","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.3748\/wjg.14.3937","volume":"14","author":"PL Lakatos","year":"2008","unstructured":"Lakatos PL, Lakatos L (2008) Risk for colorectal cancer in ulcerative colitis: changes causes and management strategies. World J Gastroenterol 14:3937\u20133947","journal-title":"World J Gastroenterol"},{"key":"719_CR26","first-page":"2727","volume":"29","author":"JK Triantafillidis","year":"2009","unstructured":"Triantafillidis JK, Nasioulas G, Kosmidis PA (2009) Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies. Anticancer Res 29:2727\u20132737","journal-title":"Anticancer Res"},{"key":"719_CR27","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/0016-5085(87)90621-4","volume":"92","author":"LR Sutherland","year":"1987","unstructured":"Sutherland LR, Martin F, Greer S et al (1987) 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology 92:1894\u20131898","journal-title":"Gastroenterology"},{"key":"719_CR28","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1053\/j.gastro.2010.11.058","volume":"140","author":"JD Lewis","year":"2011","unstructured":"Lewis JD (2011) The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease. Gastroenterology 140:1817\u20131826","journal-title":"Gastroenterology"},{"key":"719_CR29","doi-asserted-by":"crossref","unstructured":"Itzkowitz SH, Present DH, Crohn\u2019s and Colitis Foundation of America Colon Cancer in IBDSG (2005) Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis 11:314\u2013321","DOI":"10.1097\/01.MIB.0000160811.76729.d5"},{"key":"719_CR30","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000078735","volume":"22","author":"M Zalis","year":"2004","unstructured":"Zalis M, Singh AK (2004) Imaging of inflammatory bowel disease: CT and MR. Dig Dis 22:56\u201362","journal-title":"Dig Dis"},{"key":"719_CR31","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s11894-999-0042-2","volume":"1","author":"M Charron","year":"1999","unstructured":"Charron M (1999) Technetium leukocyte imaging in inflammatory bowel disease. Curr Gastroenterol Rep 1:245\u2013252","journal-title":"Curr Gastroenterol Rep"},{"key":"719_CR32","first-page":"64","volume":"53","author":"BJ Spier","year":"2009","unstructured":"Spier BJ, Perlman SB, Reichelderfer M (2009) FDG-PET in inflammatory bowel disease. Q J Nucl Med Mol Imaging 53:64\u201371","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"719_CR33","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/j.1572-0241.2004.40036.x","volume":"99","author":"A Kornbluth","year":"2004","unstructured":"Kornbluth A, Sachar DB, Practice Parameters Committee of the American College of Gastroenterology (2004) Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology Practice Parameters Committee. Am J Gastroenterol 99:1371\u20131385","journal-title":"Am J Gastroenterol"},{"key":"719_CR34","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1056\/NEJMoa050516","volume":"353","author":"P Rutgeerts","year":"2005","unstructured":"Rutgeerts P, Sandborn WJ, Feagan BG (2005) Infliximab induction and maintenance therapy for ulcerative colitis. N Engl J Med 353:2462\u20132476","journal-title":"N Engl J Med"},{"key":"719_CR35","doi-asserted-by":"crossref","first-page":"5508","DOI":"10.3748\/wjg.14.5508","volume":"14","author":"G Assche Van","year":"2008","unstructured":"Van Assche G, Vermeire S, Rutgeerts P (2008) Treatment of severe steroid refractory ulcerative colitis. World J Gastroenterol 14:5508\u20135511","journal-title":"World J Gastroenterol"},{"key":"719_CR36","first-page":"CD007216","volume":"3","author":"DC Baumgart","year":"2008","unstructured":"Baumgart DC, Macdonald JK, Feagan B (2008) Tacrolimus (FK506) for induction of remission in refractory ulcerative colitis. Cochrane Database Syst Rev 3:CD007216","journal-title":"Cochrane Database Syst Rev"},{"key":"719_CR37","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/gut.2009.183095","volume":"59","author":"CH Seow","year":"2010","unstructured":"Seow CH, Newman A, Irwin SP et al (2010) Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis. Gut 59:49\u201354","journal-title":"Gut"},{"key":"719_CR38","doi-asserted-by":"crossref","unstructured":"Di Sabatino A, Liberato L, Marchetti M et al (2011) Optimal use and cost effectiveness of biologic therapies in inflammatory bowel disease. Intern Emerg Med 6(Suppl 1):S17\u2013S27","DOI":"10.1007\/s11739-011-0673-9"},{"key":"719_CR39","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/j.1365-2036.2008.03811.x","volume":"28","author":"A Oussalah","year":"2008","unstructured":"Oussalah A, Laclotte C, Chevaux JB et al (2008) Long-term outcome of adalimumab therapy for ulcerative colitis with intolerance or lost response to infliximab: a single-centre experience. Aliment Pharmacol Ther 28:966\u2013972","journal-title":"Aliment Pharmacol Ther"},{"key":"719_CR40","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1002\/ibd.20924","volume":"15","author":"W Afif","year":"2009","unstructured":"Afif W, Leighton JA, Hanauer SB et al (2009) Open-label study of adalimumab in patients with ulcerative colitis including those with prior loss of response or intolerance to infliximab. Inflamm Bowel Dis 15:1302\u20131307","journal-title":"Inflamm Bowel Dis"},{"key":"719_CR41","first-page":"65","volume":"62","author":"AY Sklyarov","year":"2011","unstructured":"Sklyarov AY, Panasyuk NB, Fomenko IS (2011) Role of nitric oxide-synthase and cyclooxygenase\/lipooxygenase systems in development of experimental ulcerative colitis. J Physiol Pharmacol 62:65\u201373","journal-title":"J Physiol Pharmacol"},{"key":"719_CR42","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1365-2036.2010.04515.x","volume":"33","author":"T Tang","year":"2011","unstructured":"Tang T, Targan SR, Li ZS et al (2011) Randomised clinical trial: herbal extract HMPL-004 in active ulcerative colitis: a double-blind comparison with sustained release mesalazine. Aliment Pharmacol Ther 33:194\u2013202","journal-title":"Aliment Pharmacol Ther"},{"key":"719_CR43","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2165\/11205870-000000000-00000","volume":"71","author":"LP Yang","year":"2011","unstructured":"Yang LP, McCormack PL (2011) MMX\u00ae Mesalazine: a review of its use in the management of mild to moderate ulcerative colitis. Drugs 71:221\u2013235","journal-title":"Drugs"},{"key":"719_CR44","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1111\/j.1572-0241.2005.41442.x","volume":"100","author":"FS Velayos","year":"2005","unstructured":"Velayos FS, Terdiman JP, Walsh JM (2005) Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies. Am J Gastroenterol 100:1345\u20131353","journal-title":"Am J Gastroenterol"},{"key":"719_CR45","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1365-2036.2009.04023.x","volume":"30","author":"JP Gisbert","year":"2009","unstructured":"Gisbert JP, Linares PM, McNicholl AG et al (2009) Meta-analysis: the efficacy of azathioprine and mercaptopurine in ulcerative colitis. Aliment Pharmacol Ther 30:126\u2013137","journal-title":"Aliment Pharmacol Ther"},{"key":"719_CR46","first-page":"CD007560","volume":"3","author":"W Ei-Matary","year":"2009","unstructured":"Ei-Matary W, Vandermeer B, Griffiths AM (2009) Methotrexate for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev 3:CD007560","journal-title":"Cochrane Database Syst Rev"},{"key":"719_CR47","doi-asserted-by":"crossref","unstructured":"Berg DF, Bahadursingh AM, Kaminski DL et al (2002) Acute surgical emergencies in inflammatory bowel disease. Am J Surg 184:45\u201351","DOI":"10.1016\/S0002-9610(02)00879-6"},{"key":"719_CR48","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1053\/j.gastro.2004.03.063","volume":"126","author":"DW Larson","year":"2004","unstructured":"Larson DW, Pemberton JH (2004) Current concepts and controversies in surgery for IBD. Gastroenterology 126:1611\u20131619","journal-title":"Gastroenterology"},{"key":"719_CR49","doi-asserted-by":"crossref","unstructured":"Magro F, Lopes S, Rodrigues S et al (2011) How to manage pouchitis in ulcerative colitis? Curr Drug Targets 12:1454\u20131461","DOI":"10.2174\/138945011796818144"},{"key":"719_CR50","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1053\/gast.2000.9370","volume":"119","author":"P Gionchetti","year":"2000","unstructured":"Gionchetti P, Rizzello F, Venturi A et al (2000) Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 119:305\u2013309","journal-title":"Gastroenterology"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-011-0719-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11739-011-0719-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-011-0719-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T02:17:03Z","timestamp":1560910623000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11739-011-0719-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,9]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["719"],"URL":"https:\/\/doi.org\/10.1007\/s11739-011-0719-z","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,9]]}}}